TSDR/CD4 Measurement Can Distinguish Between NDM Patients with an IPEX-Causing FOXP3 Variant, Healthy Controls, and Individuals with Other Tregopathies. This evidence concerns the gene CD4 and neonatal diabetes mellitus.